Sysmex rebounded after SMBC Nikko raised its rating and price target. The Nippon Signal was viewed as a positive catalyst after reports of expanding applications for humanoid robots, while Nakanishi received an upgraded investment rating.
Sysmex rebounded today for the first time in 3 sessions. SMBC Nikko raised its investment rating on the stock from the mid-tier "2" to the top-tier "1" and raised its price target from ¥1,400 to ¥2,400. The move followed upward revisions to its earnings forecasts based on first-quarter results, policy trends and the business environment. The view is that demand for hematology products in the United States and product launches in the United States, Europe and Japan will contribute to results.
The Nippon Signal continued to rise. The morning edition of today's Nikkei reported that applications for domestically produced humanoid robots are expanding, and the report that the company plans to mass-produce robots capable of working at heights as early as 2039 was viewed as a positive catalyst. The company plans to establish a production area as part of the rebuilding of its Utsunomiya facility, produce 20 units a year and target ¥4 billion in sales for the business as a whole.
Nakanishi rebounded for the first time in 3 sessions. SMBC Nikko changed its investment rating from "2 (Neutral)" to "1 (Outperform)" and raised its price target from ¥3,300 to ¥4,000. The brokerage highlighted the company's outstanding technological capabilities and medium- to long-term business opportunities. Expectations for market expansion in the United States, replacement demand in the United States, Europe and Japan, and new products for emerging markets were viewed as positive catalysts.
In today's trading, other related stocks, including Rock Field and Densan System, also became active on favorable catalysts.